Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CLOROX CO /DE/CLX · Entity 3474 | SVP - Chief Innovation Officer | December 20, 2021 | December 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CLOROX CO /DE/
Report date December 20, 2021 · Filed December 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,980 |
Reported balance
After 2021-12-20 transaction · row 1
1 source rowRow 1 · 2021-12-20 · Tax withholding · Disposed 16 · Balance 10,980 F1: Withholding of shares by the Company to satisfy employment tax obligations applicable to restricted stock units previously granted to retirement eligible employees. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 2,178 |
Reported balance
Holding disclosure · report date 2021-12-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,178 |
Filing footnotes · ownership attribution and instrument terms
F1: Withholding of shares by the Company to satisfy employment tax obligations applicable to restricted stock units previously granted to retirement eligible employees.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 29, 2018 Filed Dec 3, 2018 21:34 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,060 | $0.00 Strike: $68.15 | $0.00 |
DisclosureSEC source: 0001225208-18-016090 · doc4.xml · derivative · entry 5 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,060 shares Expires 2021-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:34 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $72.11 | $0.00 |
DisclosureSEC source: 0001225208-18-016090 · doc4.xml · derivative · entry 4 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 Underlying: Common Stock · 3,000 shares Expires 2022-09-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:34 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 3,156 | $166.05 | $524,053.80 |
DisclosureSEC source: 0001225208-18-016090 · doc4.xml · nonDerivative · entry 3 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,948 Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:34 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 2,060 | $68.15 | $140,389.00 |
DisclosureSEC source: 0001225208-18-016090 · doc4.xml · nonDerivative · entry 2 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2018 Filed Dec 3, 2018 21:34 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 3,000 | $72.11 | $216,330.00 |
DisclosureSEC source: 0001225208-18-016090 · doc4.xml · nonDerivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,995 | $0.00 Strike: $66.48 | $0.00 |
DisclosureSEC source: 0001225208-18-015819 · doc4.xml · derivative · entry 6 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,995 shares Expires 2020-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $68.15 | $0.00 |
DisclosureSEC source: 0001225208-18-015819 · doc4.xml · derivative · entry 5 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,060 Underlying: Common Stock · 1,000 shares Expires 2021-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 1,226 | $162.39 | $199,090.14 |
DisclosureSEC source: 0001225208-18-015819 · doc4.xml · nonDerivative · entry 4 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,044 Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 621 | $162.39 | $100,844.19 |
DisclosureSEC source: 0001225208-18-015819 · doc4.xml · nonDerivative · entry 3 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,270 Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 1,000 | $68.15 | $68,150.00 |
DisclosureSEC source: 0001225208-18-015819 · doc4.xml · nonDerivative · entry 2 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 21:35 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Exercise / conversionCommon Stock | 1,995 | $66.48 | $132,627.60 |
DisclosureSEC source: 0001225208-18-015819 · doc4.xml · nonDerivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 18, 2018 Filed Sep 20, 2018 22:04 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 13,440 | $0.00 Strike: $151.85 | $0.00 |
DisclosureSEC source: 0001225208-18-013642 · doc4.xml · derivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,440 Underlying: Common Stock · 13,440 shares Expires 2028-09-18 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:49 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 63 | $146.77 | $9,246.51 |
DisclosureSEC source: 0001225208-18-012769 · doc4.xml · nonDerivative · entry 2 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,896 F2 · kind: Withholding of stock to pay certain taxes under the Company's Stock Withholding Arrangement. Read SEC document |
| August 16, 2018 Filed Aug 20, 2018 22:49 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,685 | $146.77 | $394,077.45 |
DisclosureSEC source: 0001225208-18-012769 · doc4.xml · nonDerivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,959 F1 · kind: Settlement of 2015 Performance Unit Grant that vested 8/16/2018, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 21:29 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 16,380 | $0.00 Strike: $135.57 | $0.00 |
DisclosureSEC source: 0001225208-17-015021 · doc4.xml · derivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,380 Underlying: Common Stock · 16,380 shares Expires 2027-09-12 F1 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F1 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | Tax withholdingCommon Stock | 49 | $137.17 | $6,721.33 |
DisclosureSEC source: 0001225208-17-014214 · doc4.xml · nonDerivative · entry 2 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,274 F2 · kind: Withholding of stock to pay certain taxes under the Company's Stock Withholding Arrangement. Read SEC document |
| August 17, 2017 Filed Aug 21, 2017 22:08 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantCommon Stock | 2,146 | $137.17 | $294,366.82 |
DisclosureSEC source: 0001225208-17-014214 · doc4.xml · nonDerivative · entry 1 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,323 F1 · kind: Settlement of 2014 Performance Unit Grant that vested 8/17/2017, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 20:52 UTC | CLOROX CO /DE/ CLX · Entity 3474 | GrantStock Option (Right to Buy) · Derivative | 15,470 | $0.00 Strike: $123.09 | $0.00 |
DisclosureSEC source: 0001225208-16-039392 · doc4.xml · derivative · entry 2 GARNER DENISE · CIK 0001629867 · SVP - Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,470 Underlying: Common Stock · 15,470 shares Expires 2026-09-13 F2 · kind: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. F2 · derivative.exercise_date: Option vests in 4 equal installments - 1/4 on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.